Prestige Biologics Co (XKRX:334970) FCF Yield % : -4.10 (As of Jun. 15, 2024)

Prestige Biologics Co FCF Yield % Chart

Prestige Biologics Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-27.82	-10.10	-1.72	-2.76	-10.51

Competitive Comparison of Prestige Biologics Co's FCF Yield %

For the Biotechnology subindustry, Prestige Biologics Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prestige Biologics Co's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Prestige Biologics Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Prestige Biologics Co's FCF Yield % falls into.

Prestige Biologics Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Prestige Biologics Co's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

Prestige Biologics Co's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prestige Biologics Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Prestige Biologics Co FCF Yield % Related Terms

Thank you for viewing the detailed overview of Prestige Biologics Co's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Prestige Biologics Co (XKRX:334970) Business Description